(Q34300854)

1 August 2017

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial (English)

1 reference

1 August 2017

1 reference

12

Martin S Tallman

1 reference

1 August 2017

4

Hillard M Lazarus

1 reference

1 August 2017

13

Anthony H Goldstone

1 reference

1 August 2017

3

Adele Fielding

1 reference

1 August 2017

6

Selina Luger

1 reference

1 August 2017

5

Mark R Litzow

1 reference

1 August 2017

9

Anthony V Moorman

1 reference

1 August 2017

2

Georgina Buck

1 reference

1 August 2017

Jonathan I Sive

1

1 reference

1 August 2017

David I Marks

7

1 reference

1 August 2017

Andrew McMillan

8

1 reference

1 August 2017

Susan M Richards

10

1 reference

1 August 2017

Jacob M Rowe

11

1 reference

1 August 2017

language of work or name

English

0 references

publication date

13 March 2012

1 reference

British Journal of Haematology

1 August 2017

1 reference

1 August 2017

157

1 reference

1 August 2017

4

1 reference

1 August 2017

463-471

1 reference

Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188419

Peg-asparaginase for acute lymphoblastic leukemia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188419

Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188419

Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188419

Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188419

Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188419

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188419

The treatment of acute lymphoblastic leukaemia in the elderly.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188419

Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188419

Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188419

Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study

6 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09095.X

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09095.X

Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09095.X

Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09095.X

Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09095.X

Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09095.X

Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia

21 January 2018

1 reference

12 December 2020

Acute lymphoblastic leukemia in the elderly: The Edouard Herriot Hospital experience

1 reference

12 December 2020

Acute lymphoblastic leukemia in elderly: the Polish Adult Leukemia Group (PALG) experience

1 reference

12 December 2020

Acute lymphoblastic leukemia in patients aged 60 years and over: a population-based study of incidence and outcome

1 reference

12 December 2020

Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. A Collaborative Study of the Group Français de Cytogénétique Hématologique

1 reference

12 December 2020

Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience

1 reference

12 December 2020

Acute lymphoblastic leukemia: older patients and newer drugs

1 reference

12 December 2020

Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia

1 reference

12 December 2020

A population-based cytogenetic study of adults with acute lymphoblastic leukemia

1 reference

12 December 2020

10.1111/J.1365-2141.2012.09095.X

Identifiers

DOI

1 reference

1 August 2017

1 reference

1 August 2017

1 reference